Polycythemia Vera Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014557485
Market Monitor Global
Oct-2021
Life Sciences
101 Pages

This report contains market size and forecasts of Polycythemia Vera Drug in global, including the following market information:
Global Polycythemia Vera Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Polycythemia Vera Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Polycythemia Vera Drug companies in 2020 (%)
The global Polycythemia Vera Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polycythemia Vera Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polycythemia Vera Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Polycythemia Vera Drug Market Segment Percentages, By Type, 2020 (%)
Dasatinib
Idelalisib
Givinostat
M-009
Others

Global Polycythemia Vera Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Polycythemia Vera Drug Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Polycythemia Vera Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Polycythemia Vera Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polycythemia Vera Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Polycythemia Vera Drug revenues share in global market, 2020 (%)
Key companies Polycythemia Vera Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Polycythemia Vera Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
ANP Technologies, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc.
Italfarmaco S.p.A.
Karus Therapeutics Limited
miRagen Therapeutics, Inc.
Nerviano Medical Sciences S.r.l.
Novartis AG
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Polycythemia Vera Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polycythemia Vera Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polycythemia Vera Drug Overall Market Size
2.1 Global Polycythemia Vera Drug Market Size: 2021 VS 2027
2.2 Global Polycythemia Vera Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Polycythemia Vera Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Polycythemia Vera Drug Players in Global Market
3.2 Top Global Polycythemia Vera Drug Companies Ranked by Revenue
3.3 Global Polycythemia Vera Drug Revenue by Companies
3.4 Global Polycythemia Vera Drug Sales by Companies
3.5 Global Polycythemia Vera Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Polycythemia Vera Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Polycythemia Vera Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polycythemia Vera Drug Players in Global Market
3.8.1 List of Global Tier 1 Polycythemia Vera Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Polycythemia Vera Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Polycythemia Vera Drug Market Size Markets, 2021 & 2027
4.1.2 Dasatinib
4.1.3 Idelalisib
4.1.4 Givinostat
4.1.5 M-009
4.1.6 Others
4.2 By Type - Global Polycythemia Vera Drug Revenue & Forecasts
4.2.1 By Type - Global Polycythemia Vera Drug Revenue, 2016-2021
4.2.2 By Type - Global Polycythemia Vera Drug Revenue, 2022-2027
4.2.3 By Type - Global Polycythemia Vera Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Polycythemia Vera Drug Sales & Forecasts
4.3.1 By Type - Global Polycythemia Vera Drug Sales, 2016-2021
4.3.2 By Type - Global Polycythemia Vera Drug Sales, 2022-2027
4.3.3 By Type - Global Polycythemia Vera Drug Sales Market Share, 2016-2027
4.4 By Type - Global Polycythemia Vera Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polycythemia Vera Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Polycythemia Vera Drug Revenue & Forecasts
5.2.1 By Application - Global Polycythemia Vera Drug Revenue, 2016-2021
5.2.2 By Application - Global Polycythemia Vera Drug Revenue, 2022-2027
5.2.3 By Application - Global Polycythemia Vera Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Polycythemia Vera Drug Sales & Forecasts
5.3.1 By Application - Global Polycythemia Vera Drug Sales, 2016-2021
5.3.2 By Application - Global Polycythemia Vera Drug Sales, 2022-2027
5.3.3 By Application - Global Polycythemia Vera Drug Sales Market Share, 2016-2027
5.4 By Application - Global Polycythemia Vera Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Polycythemia Vera Drug Market Size, 2021 & 2027
6.2 By Region - Global Polycythemia Vera Drug Revenue & Forecasts
6.2.1 By Region - Global Polycythemia Vera Drug Revenue, 2016-2021
6.2.2 By Region - Global Polycythemia Vera Drug Revenue, 2022-2027
6.2.3 By Region - Global Polycythemia Vera Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Polycythemia Vera Drug Sales & Forecasts
6.3.1 By Region - Global Polycythemia Vera Drug Sales, 2016-2021
6.3.2 By Region - Global Polycythemia Vera Drug Sales, 2022-2027
6.3.3 By Region - Global Polycythemia Vera Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Polycythemia Vera Drug Revenue, 2016-2027
6.4.2 By Country - North America Polycythemia Vera Drug Sales, 2016-2027
6.4.3 US Polycythemia Vera Drug Market Size, 2016-2027
6.4.4 Canada Polycythemia Vera Drug Market Size, 2016-2027
6.4.5 Mexico Polycythemia Vera Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Polycythemia Vera Drug Revenue, 2016-2027
6.5.2 By Country - Europe Polycythemia Vera Drug Sales, 2016-2027
6.5.3 Germany Polycythemia Vera Drug Market Size, 2016-2027
6.5.4 France Polycythemia Vera Drug Market Size, 2016-2027
6.5.5 U.K. Polycythemia Vera Drug Market Size, 2016-2027
6.5.6 Italy Polycythemia Vera Drug Market Size, 2016-2027
6.5.7 Russia Polycythemia Vera Drug Market Size, 2016-2027
6.5.8 Nordic Countries Polycythemia Vera Drug Market Size, 2016-2027
6.5.9 Benelux Polycythemia Vera Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Polycythemia Vera Drug Revenue, 2016-2027
6.6.2 By Region - Asia Polycythemia Vera Drug Sales, 2016-2027
6.6.3 China Polycythemia Vera Drug Market Size, 2016-2027
6.6.4 Japan Polycythemia Vera Drug Market Size, 2016-2027
6.6.5 South Korea Polycythemia Vera Drug Market Size, 2016-2027
6.6.6 Southeast Asia Polycythemia Vera Drug Market Size, 2016-2027
6.6.7 India Polycythemia Vera Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Polycythemia Vera Drug Revenue, 2016-2027
6.7.2 By Country - South America Polycythemia Vera Drug Sales, 2016-2027
6.7.3 Brazil Polycythemia Vera Drug Market Size, 2016-2027
6.7.4 Argentina Polycythemia Vera Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polycythemia Vera Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Polycythemia Vera Drug Sales, 2016-2027
6.8.3 Turkey Polycythemia Vera Drug Market Size, 2016-2027
6.8.4 Israel Polycythemia Vera Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Polycythemia Vera Drug Market Size, 2016-2027
6.8.6 UAE Polycythemia Vera Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 ANP Technologies, Inc.
7.1.1 ANP Technologies, Inc. Corporate Summary
7.1.2 ANP Technologies, Inc. Business Overview
7.1.3 ANP Technologies, Inc. Polycythemia Vera Drug Major Product Offerings
7.1.4 ANP Technologies, Inc. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.1.5 ANP Technologies, Inc. Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Polycythemia Vera Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Galena Biopharma, Inc.
7.4.1 Galena Biopharma, Inc. Corporate Summary
7.4.2 Galena Biopharma, Inc. Business Overview
7.4.3 Galena Biopharma, Inc. Polycythemia Vera Drug Major Product Offerings
7.4.4 Galena Biopharma, Inc. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.4.5 Galena Biopharma, Inc. Key News
7.5 Gilead Sciences, Inc.
7.5.1 Gilead Sciences, Inc. Corporate Summary
7.5.2 Gilead Sciences, Inc. Business Overview
7.5.3 Gilead Sciences, Inc. Polycythemia Vera Drug Major Product Offerings
7.5.4 Gilead Sciences, Inc. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.5.5 Gilead Sciences, Inc. Key News
7.6 Italfarmaco S.p.A.
7.6.1 Italfarmaco S.p.A. Corporate Summary
7.6.2 Italfarmaco S.p.A. Business Overview
7.6.3 Italfarmaco S.p.A. Polycythemia Vera Drug Major Product Offerings
7.6.4 Italfarmaco S.p.A. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.6.5 Italfarmaco S.p.A. Key News
7.7 Karus Therapeutics Limited
7.7.1 Karus Therapeutics Limited Corporate Summary
7.7.2 Karus Therapeutics Limited Business Overview
7.7.3 Karus Therapeutics Limited Polycythemia Vera Drug Major Product Offerings
7.4.4 Karus Therapeutics Limited Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.7.5 Karus Therapeutics Limited Key News
7.8 miRagen Therapeutics, Inc.
7.8.1 miRagen Therapeutics, Inc. Corporate Summary
7.8.2 miRagen Therapeutics, Inc. Business Overview
7.8.3 miRagen Therapeutics, Inc. Polycythemia Vera Drug Major Product Offerings
7.8.4 miRagen Therapeutics, Inc. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.8.5 miRagen Therapeutics, Inc. Key News
7.9 Nerviano Medical Sciences S.r.l.
7.9.1 Nerviano Medical Sciences S.r.l. Corporate Summary
7.9.2 Nerviano Medical Sciences S.r.l. Business Overview
7.9.3 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Major Product Offerings
7.9.4 Nerviano Medical Sciences S.r.l. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.9.5 Nerviano Medical Sciences S.r.l. Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Polycythemia Vera Drug Major Product Offerings
7.10.4 Novartis AG Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.10.5 Novartis AG Key News
7.11 PharmaEssentia Corporation
7.11.1 PharmaEssentia Corporation Corporate Summary
7.11.2 PharmaEssentia Corporation Polycythemia Vera Drug Business Overview
7.11.3 PharmaEssentia Corporation Polycythemia Vera Drug Major Product Offerings
7.11.4 PharmaEssentia Corporation Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.11.5 PharmaEssentia Corporation Key News
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.12.2 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Business Overview
7.12.3 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Major Product Offerings
7.12.4 Teva Pharmaceutical Industries Ltd. Polycythemia Vera Drug Sales and Revenue in Global (2016-2021)
7.12.5 Teva Pharmaceutical Industries Ltd. Key News
8 Global Polycythemia Vera Drug Production Capacity, Analysis
8.1 Global Polycythemia Vera Drug Production Capacity, 2016-2027
8.2 Polycythemia Vera Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Polycythemia Vera Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polycythemia Vera Drug Supply Chain Analysis
10.1 Polycythemia Vera Drug Industry Value Chain
10.2 Polycythemia Vera Drug Upstream Market
10.3 Polycythemia Vera Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polycythemia Vera Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Polycythemia Vera Drug in Global Market
Table 2. Top Polycythemia Vera Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Polycythemia Vera Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Polycythemia Vera Drug Revenue Share by Companies, 2016-2021
Table 5. Global Polycythemia Vera Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Polycythemia Vera Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Polycythemia Vera Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Polycythemia Vera Drug Product Type
Table 9. List of Global Tier 1 Polycythemia Vera Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polycythemia Vera Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

ANP Technologies, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc.
Italfarmaco S.p.A.
Karus Therapeutics Limited
miRagen Therapeutics, Inc.
Nerviano Medical Sciences S.r.l.
Novartis AG
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE